Friday, April 15, 2016 9:00:58 AM
http://investor.relypsa.com/sec.cfm
The 8-K goes over the end of month scripts. I had to reformat from the 8-K, hopefully that kept it clear.
March 1-31, 2016
In the outpatient setting:
• 1,277 new patients started taking Veltassa with a free-starter supply.
• 706 outpatient prescriptions were covered by payers and dispensed (retail TRx).
In the hospital/institution setting:
• 201 units were sold to hospitals and other institutions (non-retail).
Overall Quarterly Numbers
Outpatient setting
New patients who started taking Veltassa with a free starter-supply
Jan: 409 (average 102 patients/week)
Feb: 812 (average 203 patients/week)
Mar: 1,277 (average 290 patients/week)
Q1 : 2,498
Outpatient prescriptions covered and dispensed (retail TRx)
Jan: 99 (average 25 prescriptions/week)
Feb: 350 (average 87 prescriptions/week)
Mar: 706 (average 160 prescriptions/week)
Q1 : 1,155
Hospital/institution setting
Hospital/institution units sold (non-retail)
Jan: 56 (average 14 units/week)
Feb: 117 (average 29 units/week)
Mar: 201 (average 46 units/week)
Q1 : 374
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM